4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001140361-13-027077
CIK 0001069308operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 2:42 PM ET
Size
6.1 KB
Accession
0001140361-13-027077
Insider Transaction Report
Form 4
Seaman Scott B
Director
Transactions
- Award
Common Stock
2013-06-30$1.54/sh+19,345$29,791→ 249,526 total(indirect: See footnote)
Footnotes (2)
- [F1]On June 30, 2013, 19,345 shares of Common Stock were issued to Alkek & Williams Ventures Ltd ("Ventures") as payment-in-kind for interest accrued as of June 30, 2013 on a 12% Convertible Secured Promissory Note held by Ventures in the principal amount of $500,000. The shares issued in payment of accrued interest payable on the interest payment date were deemed to have a value equal to the volume weighted average price for the Common Stock for the five trading days ending three trading days prior to the payment date.
- [F2]Held by Ventures. Chaswil, Ltd. ("Chaswil") is the investment manager of Ventures and holds voting power and investment power with respect to the Issuer securities held by Ventures. Mr. Seaman is a registered principal of Chaswil and has shared voting power and/or investment power with respect to the Issuer securities held by Ventures.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 2:42 PM ET
- Size
- 6.1 KB